Illumina, Inc. (ILMN)
210.91
+3.78
(+1.82%)
USD |
NASDAQ |
Sep 02, 13:18
Illumina Research and Development Expense (Annual) : 951.00M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 951.00M |
| December 31, 2024 | 1.167B |
| December 31, 2023 | 1.33B |
| December 31, 2022 | 1.321B |
| December 31, 2021 | 1.185B |
| December 31, 2020 | 682.00M |
| December 31, 2019 | 647.00M |
| December 31, 2018 | 623.00M |
| December 31, 2017 | 541.00M |
| December 31, 2016 | 504.42M |
| December 31, 2015 | 401.53M |
| December 31, 2014 | 337.75M |
| December 31, 2013 | 276.20M |
| December 31, 2012 | 227.61M |
| Date | Value |
|---|---|
| December 31, 2011 | 192.11M |
| December 31, 2010 | 177.95M |
| December 31, 2009 | 140.62M |
| December 31, 2008 | 99.96M |
| December 31, 2007 | 73.94M |
| December 31, 2006 | 29.48M |
| December 31, 2005 | 27.72M |
| December 31, 2004 | 21.11M |
| December 31, 2003 | 22.51M |
| December 31, 2002 | 26.85M |
| December 31, 2001 | 23.85M |
| December 31, 2000 | 11.95M |
| December 31, 1999 | 4.086M |
| December 31, 1998 | 0.7709M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Agilent Technologies, Inc. | 450.00M |
| Danaher Corp. | 1.598B |
| Thermo Fisher Scientific, Inc. | 1.397B |
| Pacific Biosciences of California, Inc. | 95.21M |
| Bio-Rad Laboratories, Inc. | 257.60M |